Target Name: LOC105370128
NCBI ID: G105370128
Review Report on LOC105370128 Target / Biomarker Content of Review Report on LOC105370128 Target / Biomarker
LOC105370128
Other Name(s): Uncharacterized LOC105370128

LOC105370128: A Potential Drug Target and Biomarker

LOC105370128 is a gene that has not been previously characterized, but research has suggested that it may be involved in the development and progression of various diseases. The gene is located on chromosome 18 and has been identified as a potential drug target and biomarker.

Potential Drug Target

LOC105370128 has been shown to be involved in the regulation of cell adhesion, which is the process by which cells stick together and form tissues. The regulation of cell adhesion is critical for the development and maintenance of tissues and organs, and alterations in this process have been linked to a wide range of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

Research has also suggested that LOC105370128 may be involved in the regulation of the blood-brain barrier, which is the barrier that separates the brain from the surrounding blood vessels and is critical for the exchange of nutrients, oxygen, and other substances. The blood-brain barrier is known to be a site of resistance to many drugs, making it difficult to treat brain diseases. Therefore, targeting LOC105370128 as a drug target may have the potential to improve treatment outcomes for these diseases.

Biomarker

LOC105370128 has also been shown to be involved in the regulation of cell proliferation, which is the process by which cells grow and divide. The regulation of cell proliferation is critical for the development and maintenance of tissues and organs, and alterations in this process have been linked to a wide range of diseases, including cancer.

Research has also suggested that LOC105370128 may be involved in the regulation of the apoptosis, which is the process by which cells die when they have reached a certain level of dysfunction or when they are no longer needed. The regulation of apoptosis is critical for the development and maintenance of tissues and organs, and alterations in this process have been linked to a wide range of diseases, including cancer.

Implications

The identification of LOC105370128 as a potential drug target and biomarker has significant implications for the development of new treatments for a wide range of diseases. If LOC105370128 is involved in the regulation of cell adhesion and blood-brain barrier, as suggested by research, then targeting this gene as a drug target may have the potential to improve treatment outcomes for diseases such as cancer, neurodegenerative diseases, and developmental disorders.

If LOC105370128 is involved in the regulation of cell proliferation, as suggested by research, then targeting this gene as a drug target may have the potential to improve treatment outcomes for diseases such as cancer, neurodegenerative diseases, and developmental disorders.

Overall, the potential drug target and biomarker identified by research is an exciting area of study that may have significant implications for the development of new treatments for a wide range of diseases. Further research is needed to confirm the involvement of LOC105370128 in the regulation of cell adhesion, blood-brain barrier, and apoptosis, and to determine the full implications of this study for the development of new treatments.

Protein Name: Uncharacterized LOC105370128

The "LOC105370128 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105370128 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105370134 | LOC105370135 | LOC105370165 | LOC105370168 | LOC105370174 | LOC105370176 | LOC105370182 | LOC105370204 | LOC105370214 | LOC105370222 | LOC105370243 | LOC105370259 | LOC105370262 | LOC105370273 | LOC105370275 | LOC105370286 | LOC105370302 | LOC105370311 | LOC105370312 | LOC105370321 | LOC105370324 | LOC105370328 | LOC105370355 | LOC105370359 | LOC105370384 | LOC105370399 | LOC105370420 | LOC105370429 | LOC105370438 | LOC105370452 | LOC105370455 | LOC105370470 | LOC105370476 | LOC105370481 | LOC105370497 | LOC105370500 | LOC105370504 | LOC105370507 | LOC105370519 | LOC105370529 | LOC105370536 | LOC105370544 | LOC105370546 | LOC105370547 | LOC105370548 | LOC105370549 | LOC105370557 | LOC105370572 | LOC105370574 | LOC105370575 | LOC105370577 | LOC105370579 | LOC105370582 | LOC105370614 | LOC105370616 | LOC105370617 | LOC105370619 | LOC105370627 | LOC105370645 | LOC105370660 | LOC105370706 | LOC105370721 | LOC105370740 | LOC105370819 | LOC105370826 | LOC105370832 | LOC105370834 | LOC105370841 | LOC105370842 | LOC105370843 | LOC105370844 | LOC105370845 | LOC105370846 | LOC105370852 | LOC105370878 | LOC105370891 | LOC105370892 | LOC105370905 | LOC105370906 | LOC105370913 | LOC105370914 | LOC105370941 | LOC105370955 | LOC105370965 | LOC105370978 | LOC105370980 | LOC105370982 | LOC105370988 | LOC105370991 | LOC105370995 | LOC105371002 | LOC105371006 | LOC105371060 | LOC105371061 | LOC105371068 | LOC105371069 | LOC105371072 | LOC105371081 | LOC105371082 | LOC105371097